Trial reportPloS one2025
Partial blue light blocking glasses at night advanced sleep phase and reduced daytime irritability, disruptive behavior and improved morning mood, but did not alter salivary melatonin secretion in Japanese male schoolchildren.
Trial report in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In modern society, delayed sleep patterns among schoolchildren present challenges to academic attendance and performance. The impact of nighttime light exposure, especially blue wavelength light, on sleep delay has long been acknowledged. We investigated the effects of using partial blue light blocking glasses (JINS Screen Lens Heavy [40% cut]) on salivary melatonin levels, sleep patterns, sleep circadian phase, and daytime behavior in 39 male schoolchildren aged 10-12 who regularly wear glasses for myopia. Participants alternated between blue light blocking and standard clear lens glasses, both providing vision correction, for three hours before their habitual bedtime. The study was conducted over five weeks using a crossover design with two-week glasses-wearing sessions and a one-week washout interval between conditions. While blue light blocking glasses did not influence salivary melatonin levels, they significantly advanced the sleep phase (bedtime: 22.03 ± 0.08h vs. 22.13 ± 0.09h, p = 0.040, sleep onset: 22.26 ± 0.08h vs. 22.36 ± 0.10h, p = 0.041). The effects were more pronounced in the second week and accompanied by reduced irritability and disruptive behavior during daytime. Our results suggest that wearing blue light blocking glasses before bedtime may advance the sleep phase and improve daytime behavior in schoolchildren under real-world living conditions, warranting further mechanistic investigation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.